Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Verinurad

Verinurad is listed in the pharmaceutical impurity collection under CAS 1352792-74-5. Its represented structure has formula C20H16N2O2S and a calculated molecular weight of 348.43 g/mol.

2D chemical structure

S N N O H O

Chemical identity

Catalog name
Verinurad
Common name
Verinurad
Chemical name
2-[[3-(4-cyanonaphthalen-1-yl)-4-pyridinyl]sulfanyl]-2-methylpropanoic acid
CAS
1352792-74-5
SMILES
CC(C)(Sc1ccncc1-c1ccc(C#N)c2ccccc12)C(=O)O
InChI
InChI=1S/C20H16N2O2S/c1-20(2,19(23)24)25-18-9-10-22-12-17(18)16-8-7-13(11-21)14-5-3-4-6-15(14)16/h3-10,12H,1-2H3,(H,23,24)
InChIKey
YYBOLPLTQDKXPM-UHFFFAOYSA-N

Record ID: Aef6701ddf62e

Computed properties

C20H16N2O2S Molecular formula
348.427 g/molMolecular weight
348.0932 DaMonoisotopic exact mass
73.98 ŲTopological polar surface area
4.7288 Calculated LogP (Wildman–Crippen)
99.4658 cm³/molMolar refractivity (Wildman–Crippen)
4 countHydrogen-bond acceptors
1 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H N O S 0 5 10 15 20 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight348.42757.67
Calculated LogP (Wildman–Crippen)4.728887.22
Topological polar surface area73.9852.95
Hydrogen-bond acceptors450.68
Hydrogen-bond donors138.08
Rotatable bonds (strict)449.39

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC20H16N2O2Sdimensionless
Molecular weight348.427g/mol
Monoisotopic exact mass348.0932Da
Topological polar surface area73.98Ų
Calculated LogP (Wildman–Crippen)4.7288dimensionless
Molar refractivity (Wildman–Crippen)99.4658cm³/mol
Hydrogen-bond acceptors4count
Hydrogen-bond donors1count
Rotatable bonds (strict)4count
Heavy atoms25count
Heteroatoms5count
Rings3count
Aromatic rings3count
Aliphatic rings0count
Saturated rings0count
Aromatic heterocycles1count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles2count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.15fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area149.686Ų
Valence electrons124count
Radical electrons0count
Bertz complexity1,005.9939index
Balaban J2.2095index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Verinurad

Qualification and safety assessment of Verinurad

Explore toxicological qualification of Verinurad and ICH M7 mutagenic impurity assessment of Verinurad for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Verinurad and acceptable intake and limit justification for Verinurad. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Verinurad

Explore Altox services and software through the Altox Pharma-Hub.